| Bacillus spizizenii |
Bacillus spizizenii |
MIC |
0.4 |
ug.mL-1 |
10.1021/jm00215a025 |
| Bacteria |
Bacterial 70S ribosome |
IC50 |
1200.0 |
nM |
10.1021/jm00215a025 |
| Bacteria |
Bacterial 70S ribosome |
pK50 |
5.9 |
None |
10.1021/jm00215a025 |
| Chlamydia psittaci 6BC |
Chlamydia psittaci 6BC |
MIC |
0.05 |
ug.mL-1 |
10.1128/aac.00962-07 |
| Chlamydia psittaci 6BC |
Chlamydia psittaci 6BC |
MIC |
10.0 |
ug.mL-1 |
10.1128/aac.00962-07 |
| Chlamydia trachomatis |
Chlamydia trachomatis |
MIC |
0.05 |
ug.mL-1 |
10.1128/aac.00962-07 |
| Chlamydia trachomatis |
Chlamydia trachomatis |
MIC |
0.2 |
ug.mL-1 |
10.1128/aac.00962-07 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00481-08 |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1128/aac.01266-07 |
| Escherichia coli |
Escherichia coli |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.01048-06 |
| Escherichia coli |
Escherichia coli |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00481-08 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00481-08 |
| Escherichia coli |
Escherichia coli |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.01048-06 |
| Escherichia coli |
Escherichia coli |
MIC |
512.0 |
ug.mL-1 |
10.1128/aac.01048-06 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
IB3-1 |
Activity |
nan |
None |
10.1128/aac.01142-06 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Proteinase-activated receptor 2 |
Inhibition |
nan |
% |
10.1128/aac.00140-07 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
25.0 |
ug.mL-1 |
10.1021/jm00215a025 |
| Mus musculus |
P-glycoprotein 3 |
Activity |
nan |
None |
10.1046/j.1440-1681.2000.03308.x |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC |
0.007 |
ug.mL-1 |
10.1128/aac.01684-08 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC |
0.01 |
ug.mL-1 |
10.1128/aac.01563-08 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC |
0.0156 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC |
0.0625 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC |
0.1 |
ug.mL-1 |
10.1128/aac.01563-08 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC50 |
0.0313 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.01684-08 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC50 |
8.0 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC50 |
32.0 |
ug.mL-1 |
10.1128/aac.01563-08 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC50 |
64.0 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC90 |
0.0625 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC90 |
4.0 |
ug.mL-1 |
10.1128/aac.01684-08 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC90 |
16.0 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC90 |
64.0 |
ug.mL-1 |
10.1128/aac.00779-07 |
| Mycoplasmoides pneumoniae |
Mycoplasmoides pneumoniae |
MIC90 |
64.0 |
ug.mL-1 |
10.1128/aac.01563-08 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
8.86 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.08039 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.05 |
% |
10.6019/CHEMBL4495565 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.029 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00481-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.01583-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.6 |
ug.mL-1 |
10.1021/jm00215a025 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.029 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.029 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.01583-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2000.0 |
ug.mL-1 |
10.1128/aac.01583-07 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.029 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.029 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.029 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
Activity |
1.0 |
ug ml-1 |
10.1128/aac.00157-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
Activity |
4.0 |
ug ml-1 |
10.1128/aac.00157-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
Activity |
87.2 |
% |
10.1128/aac.00157-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00157-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00157-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00157-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC90 |
2.0 |
ug.mL-1 |
10.1128/aac.00157-07 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
IZ |
10.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
IZ |
13.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
IZ |
17.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces alboniger |
Streptomyces alboniger |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces alboniger |
Streptomyces alboniger |
IZ |
14.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces alboniger |
Streptomyces alboniger |
IZ |
15.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
11.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
15.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
17.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
21.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
29.0 |
mm |
10.1584/jpestics.28.183 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
20.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00481-08 |
| None |
Ribosome |
Activity |
nan |
None |
10.1021/acs.jnatprod.7b00133 |
| None |
Unchecked |
Activity |
nan |
None |
10.1128/aac.01142-06 |
| None |
Unchecked |
Hepatotoxicity (acute) |
9.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
6.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.7b00133 |